Abstract
This paper describes the inhibition of human immunodeficiency virus-type 1 (HIV-1) virus replication in tumor cell lines by marine dolastanes (1–3) and secodolastane diterpenes (2) isolated from brown alga, Canistrocarpus cervicornis. Cells were exposed to CXCR4-tropic HIV-1 and treated with different concentrations of the compounds. We observed that the compounds inhibit HIV-1 replication in a dose-dependent manner with EC50 values of 0.35, 3.67, and 0.794 μM for diterpenes 1, 2, and 3, respectively. We demonstrate that these compounds present no cytotoxic effect with CC50 values ranging from 935 to 1910 μM. We also analyzed the virucidal effect of these compounds and observed that dolastane diterpenes 1 and 3 present a potent effect on a HIV-1 infectivity of up to 99 and 87 %, respectively, at a concentration of 25 μM. No virucidal effect was observed with secodolastane diterpene 2. Our results support further investigations on compounds 1 and 3 for pre-exposure prophylaxis (PrEP) and suggest that the microbicidal compounds act before virus penetration into target cells. We propose that these marine diterpenes could be considered as a potential HIV-1 therapy.



Similar content being viewed by others
Explore related subjects
Discover the latest articles and news from researchers in related subjects, suggested using machine learning.References
Adamson CS, Freed EO (2010) Novel approaches to inhibiting HIV-1 replication. Antiviral Res 85:119–141
Ali Biswas H (2014) On the evolution of AIDS/HIV treatment: an optimal control approach. Curr HIV Res 12:1–12
Ammassari A, Trotta MP, Shalev N, Marconi P, Antinori A (2012) Beyond virological suppression: the role of adherence in the late HAART era. Antivir Ther 17:785–792
Broder S (2010) The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic. Antiviral Res 85:1–18
Chaix F, Goujard C (2009) Actualités sur les traitements de l’infection par le virus de l’immunodéficience humaine. Rev Med Interne 30:543–554 (in French)
Cirne-Santos CC, Souza TM, Teixeira VL, Fontes CF, Rebello MA, Castello-Branco LR, Abreu CM, Tanuri A, Frugulhetti IC, Bou-Habib DC (2008) The dolabellane diterpene Dolabelladienetriol is a typical noncompetitive inhibitor of HIV-1 reverse transcriptase enzyme. Antiviral Res 77:64–71
Cirne-Santos CC, Teixeira VL, Castello-Branco LR, Frugulhetti IC, Bou-Habib DC (2006) Inhibition of HIV-1 replication in human primary cells by a dolabellane diterpene isolated from the marine algae Dictyota pfaffii. Planta Med 72:295–299
Damonte EB, Matulewicz MC, Cerezo AS (2004) Sulfated seaweed polysaccharides as antiviral agents. Curr Med Chem 11:2399–2419
Dimitrov D, Boily MC, Brown ER, Hallett TB (2013) Analytic review of modeling studies of ARV Based PrEP interventions reveals strong influence of drug-resistance assumptions on the population-level effectiveness. PLoS One 8, e80927
FDA (2014) FDA-Approved HIV Medicines. http://aidsinfo.nih.gov/education-materials/fact-sheets/print/21/58/0/0. http://aidsinfo.nih.gov/education-materials/fact-sheets/print/21/58/0/0. Accessed on 07 April 2015
Fettig J, Swaminathan M, Murrill CS, Kaplan JE (2014) Global epidemiology of HIV. Infect Dis Clin North Am 28:323–337
Kim SK, Karadeniz F (2011) Anti-HIV activity of extracts and compounds from marine algae. Adv Food Nutr Res 64:255–265
Koharudin LM, Gronenborn AM (2014) Antiviral lectins as potential HIV microbicides. Curr Opin Virol 7c:95–100
May MT, Ingle SM (2011) Life expectancy of HIV-positive adults: a review. Sex Health 8:526–533
Ngo DH, Kim SK (2013) Sulfated polysaccharides as bioactive agents from marine algae. Int J Biol Macromol 62:70–75
Pardo-Vargas A, Ramos FA, Cirne-Santos CC, Stephens PR, Paixão ICP, Teixeira VL, Castellanos L (2014) Semi-synthesis of oxygenated dolabellane diterpenes with highly in vitro anti-HIV-1 activity. Bioorg Med Chem Lett 24:4381–4383
Pau AK, George JM (2014) Antiretroviral therapy: current drugs. Infect Dis Clin North Am 28:371–402
Peterson CW, Younan P, Jerome KR, Kiem H-P (2013) Combinatorial anti-HIV gene therapy: using a multipronged approach to reach beyond HAART. Gene Ther 20:695–702
Ravetti S, Gualdesi MS, Trinchero-Hernandez JS, Turk G, Brinon MC (2009) Synthesis and anti-HIV activity of novel 2',3'-dideoxy-3'-thiacytidine prodrugs. Bioorg Med Chem 17:6407–6413
Rohan LC, Sassi AB (2009) Vaginal drug delivery systems for HIV prevention. AAPS J 11:78–87
Talwar GP, Dar SA, Rai MK, Reddy KV, Mitra D, Kulkarni SV, Doncel GF, Buck CB, Schiller JT, Muralidhar S, Bala M, Agrawal SS, Bansal K, Verma JK (2008) A novel polyherbal microbicide with inhibitory effect on bacterial, fungal and viral genital pathogens. Int J Antimicrob Agents 32:180–185
Tancredi MV, Waldman EA (2014) Predictors of progression to AIDS after HIV infection diagnosis in the pre- and post-HAART eras in a Brazilian AIDS-free cohort. Trans Roy Soc Trop Med Hyg 108:408–414
Teixeira VL, Tomassini T, Fleury BG, Kelecom A (1986) Dolastane and secodolastane diterpenes from the marine brown alga, Dictyota cericornis. J Nat Prod 49:570–575
Acknowledgments
The authors are grateful to CNPq (Conselho Nacional de Desenvolvimento Científico e Tecnológico) for financial support and for Productivity Fellowships to ICNPP (303368/2013-6) and VLT (301420/2010-6). ICNPP (E-26/103.024/2011) and VLT (E-26/103.176/2011) also thank the FAPERJ (Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro) for the Cientista do Nosso Estado Fellowship. CSB thanks FAPERJ for the DSc fellowship (E-26/100.770/2012). CCCS thanks FAPERJ for the PHD fellowship (E-26/101.919/2009).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
de Souza Barros, C., Cirne-Santos, C.C., Garrido, V. et al. Anti-HIV-1 activity of compounds derived from marine alga Canistrocarpus cervicornis . J Appl Phycol 28, 2523–2527 (2016). https://doi.org/10.1007/s10811-015-0776-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10811-015-0776-1


